Watson Pharmaceuticals acquires Eden Biodesign - MarketLine Financial Deals

Watson Pharmaceuticals acquires Eden Biodesign

Watson Pharmaceuticals acquires Eden Biodesign - MarketLine Financial Deals
Watson Pharmaceuticals acquires Eden Biodesign
Published Jan 28, 2010
2 pages — Published Jan 28, 2010
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Watson Pharmaceuticals, Inc., a US-based pharmaceutical company, has acquired Eden Biopharm, Ltd., a UK-based biopharmaceutical development and contract manufacturing company.

  
Source:
Document ID
MA18253_100201
Country
Country
Ticker
WPI=US
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Watson Pharmaceuticals acquires Eden Biodesign" Jan 28, 2010. Alacra Store. Dec 04, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Watson-Pharmaceuticals-acquires-Eden-Biodesign-2052-22941>
  
APA:
MarketLine Financial Deals. (2010). Watson Pharmaceuticals acquires Eden Biodesign Jan 28, 2010. New York, NY: Alacra Store. Retrieved Dec 04, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Watson-Pharmaceuticals-acquires-Eden-Biodesign-2052-22941>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.